Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease

J Dermatol. 2019 Mar;46(3):e83-e84. doi: 10.1111/1346-8138.14627. Epub 2018 Sep 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antigens, Neoplasm / blood*
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / blood*
  • Docetaxel / therapeutic use*
  • Female
  • Humans
  • Keratin-19 / blood*
  • Neoplasm Staging
  • Paget Disease, Extramammary / blood
  • Paget Disease, Extramammary / drug therapy*
  • Paget Disease, Extramammary / pathology
  • Paget Disease, Extramammary / therapy
  • Palliative Care / methods
  • Skin Neoplasms / blood
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy
  • Treatment Outcome
  • Vulva / pathology
  • Vulva / surgery

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Keratin-19
  • antigen CYFRA21.1
  • Docetaxel